Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00219583 |
Recruitment Status
:
Completed
First Posted
: September 22, 2005
Last Update Posted
: November 7, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Ejaculation | Drug: UK-390,957 | Phase 2 Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 460 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double |
Primary Purpose: | Treatment |
Official Title: | A Phase 2b, Multi-Centre, Double-Blind, Placebo-Controlled, Parallel Group Dose Response Study To Assess The Efficacy and Safety Of Oral UK390,957 In Men With Premature Ejaculation |
Study Start Date : | August 2004 |
Actual Primary Completion Date : | June 2005 |
Actual Study Completion Date : | June 2005 |
- Assessment of efficacy and safety
- Assessment of quality of sexual life

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Premature ejaculation as defined by DSM-IV
Exclusion Criteria:
- History of erectile dysfunction

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00219583

Study Director: | Pfizer CT.gov Call Center | Pfizer |
Additional Information:
Responsible Party: | Pfizer |
ClinicalTrials.gov Identifier: | NCT00219583 History of Changes |
Other Study ID Numbers: |
A3871027 |
First Posted: | September 22, 2005 Key Record Dates |
Last Update Posted: | November 7, 2012 |
Last Verified: | November 2012 |
Additional relevant MeSH terms:
Premature Ejaculation Sexual Dysfunction, Physiological Genital Diseases, Male Sexual Dysfunctions, Psychological Mental Disorders |